15 Mar 2021late filing notice▼ Bad
VERDE BIO HOLDINGS, INC. notified the SEC that its annual report would be filed late.
Announcements, explained
Each one in plain English, with the numbers worked through for a shareholder.
11 Mar 2021asset acquisition disposition▲ Good
The $150,000 royalty acquisition announced in February closed.
2 Mar 2021substantial holder notice● Neutral
GPL Ventures LLC disclosed a new substantial VERDE BIO HOLDINGS, INC. shareholding (8.50% of votes).
2 Mar 2021material agreement▲ Good
Verde Bio agreed to buy more royalty interests, this time for $150,000 cash rather than stock -- its business model shifting toward cash-funded acquisitions as it grew.
11 Feb 2021capital raising announcement▼ Bad
Verde Bio took another Power Up Lending Group convertible note, $43,500 on the same 12%/42%-of-market terms - filed as an identical duplicate 8-K under a separate accession number the same day, so this may represent one note counted twice rather than two.
11 Feb 2021capital raising announcement▼ Bad
Verde Bio took another Power Up Lending Group convertible note, $43,500 on the same 12%/42%-of-market terms - filed as an identical duplicate 8-K under a separate accession number the same day, so this may represent one note counted twice rather than two.
5 Feb 2021securities registration● Neutral
VERDE BIO HOLDINGS, INC. filed a post-qualification amendment to its Regulation A offering.
25 Jan 2021capital raising announcement▼ BadMajor
Verde Bio added a third toxic-note lender, Power Up Lending Group: a $55,500 convertible note at 12% interest, convertible after 180 days at a 42% discount to market.
11 Jan 2021securities registration● Neutral
VERDE BIO HOLDINGS, INC. amended a filing by which it filed a Regulation A offering statement.
6 Jan 2021capital raising announcement▼ BadMajor
Verde Bio took on a new toxic-style lender alongside GHS: a $30,556 convertible note from Quick Capital, LLC at 10% interest, convertible at a steep discount (the lesser of $0.01 or 50% of market).
16 Dec 2020late filing notice▼ Bad
VERDE BIO HOLDINGS, INC. notified the SEC that its quarterly report would be filed late.
17 Nov 2020capital raising announcement▼ Bad
Verde Bio took a fifth GHS Investments convertible note, $35,000 on the same 10%/60%-of-market terms, bringing this round of GHS notes to roughly $186,000 before their 2021 payoff.
17 Nov 2020securities registration● Neutral
VERDE BIO HOLDINGS, INC. amended a filing by which it registered a securities offering with the SEC.
13 Nov 2020securities registration● Neutral
VERDE BIO HOLDINGS, INC. filed a Regulation A offering statement.
15 Oct 2020securities registration● Neutral
VERDE BIO HOLDINGS, INC. amended a filing by which it registered a securities offering with the SEC.
1 Oct 2020material agreement▲ Good
Verde Bio agreed to buy more mineral and royalty interests from a private seller for 5 million shares, continuing to build its royalty portfolio.
28 Sept 2020capital raising announcement▼ Bad
Verde Bio took a fourth GHS Investments convertible note, $35,000 on the same 10%/60%-of-market terms.
15 Sept 2020late filing notice▼ Bad
VERDE BIO HOLDINGS, INC. notified the SEC that its quarterly report would be filed late.
20 Aug 2020securities registration● Neutral
VERDE BIO HOLDINGS, INC. registered a securities offering with the SEC.
30 July 2020material agreement▲ GoodMajor
Now renamed Verde Bio Holdings, the company made its first oil and gas move: agreeing to buy mineral and royalty interests from a private seller for 10 million shares of stock -- the start of its actual current business as a rolling acquirer of small oil and gas royalty packages.
4 June 2020capital raising announcement▼ BadMajor
Verde Bio lined up a $5 million GHS Investments equity line ahead of its oil-and-gas pivot, and separately issued 24.5 million shares to consultants and service providers - including 20 million shares to sole director and CEO Scott Cox, who approved his own grant.
7 May 2020material agreement● Neutral
The company signed another consulting agreement (with Lifetime Insurance & Risk Planning) for general corporate-growth advice, still before the pivot to oil and gas royalties was announced.
30 Mar 2020capital raising announcement▼ Bad
Appiphany took a third GHS Investments convertible note, $13,000 on the same 10%/60%-of-market terms.
13 Mar 2020quarterly activities report● Neutral
VERDE BIO HOLDINGS, INC. reported quarterly revenue of $0 for the period ended 2020-01-31.
12 Feb 2020capital raising announcement● NeutralMajor
Appiphany formed a hemp seed and genetics joint venture with Tsilaan, LLC and Kola Venture Group, taking a 25% stake for $300,000 cash plus 1.5 million shares issued to its partners - a concrete step on the hemp pivot floated weeks earlier.
3 Feb 2020capital raising announcement▼ Bad
Appiphany took a second GHS Investments convertible note, $68,000 on the same 10%/60%-of-market terms as the note three weeks earlier.
3 Feb 2020material agreement● Neutral
Under new leadership, the company (still named Appiphany) briefly explored a pivot toward the hemp industry, hiring Mustang Capital as a consultant on hemp-related acquisitions and ventures.
21 Jan 2020capital raising announcement▼ BadMajor
Appiphany took on its first GHS Investments convertible note, $35,000 at 10% interest, convertible at a 60% discount to market - the start of the toxic-note debt load that would later cost $715,000 to unwind in 2021.
12 Dec 2019business combination▲ GoodMajor
Scott Cox took voting control of the company (by then still Appiphany) through a purchase of super-voting Series A Preferred shares, replacing Robert Sargent as sole director -- the change-of-control event that set up the company's later pivot into oil and gas as Verde Bio Holdings.
28 Aug 2019quarterly activities report▼ Bad
VERDE BIO HOLDINGS, INC. reported a quarterly net loss of $386 thousand for the period ended 2019-07-31.